CLOV vs HLIO · rev $1.37B vs P/E 47, rev $805.9M
Clover Health Investments Corp (CLOV) versus Helios Technologies Inc (HLIO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Helios Technologies Inc (HLIO) is a specialty industrial machinery company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported HLIO revenue for 2024-12-28 was $805.9M. Net income was $39.0M. Revenue was down 3.6% from 2023-12-30 to 2024-12-28. HLIO currently screens at market cap $2.84B and trailing P/E 47.2.
CLOV currently screens at market cap $1.55B. HLIO currently screens at market cap $2.84B and trailing P/E 47.2.
Not investment advice. Open the CLOV and HLIO stock pages for the full models.
Not investment advice.